These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7654069)

  • 21. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic marker of acute motor axonal neuropathy in childhood.
    Nishimoto Y; Susuki K; Yuki N
    Pediatr Neurol; 2008 Jul; 39(1):67-70. PubMed ID: 18555178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.